Here, we found that Dox-resistant cells express higher levels of Trx-1 gene and that downregulation of Trx-1 in these cells reversed the chemoresistant phenotype, suggesting that the high expression of Trx-1 in DLBCL may have been acquired during chemotherapy. Here, TXN is linked to diffuse large B-cell lymphoma.